As part of the worldwide effort in the field of life sciences, to deal with the outbreak of COVID 19, scientists from the 'Migal HaGalil' research institute in Israel are using Dassault Systèmes' BIOVIA applications to accelerate their research and development of a possible vaccine against SARS CoV 2 (the corona virus)
As part of the worldwide effort in the field of life sciences, to deal with the outbreak of COVID 19, scientists from the 'Migal HaGalil' research institute in Israel are using Dassault Systèmes' BIOVIA applications to accelerate their research and development of a possible vaccine against SARS CoV 2 (the corona virus).
Migel used BIOVIA applications, in addition to a variety of computational tools, for four years of multidisciplinary research in projects to develop vaccines against avian viruses from the coronavirus family. When COVID 19 became a pandemic, this academic research and development center - which focuses on plant sciences, agriculture, environmental sciences, computer science, nutrition and biotechnology - began to use these applications and computational tools to apply its research to the investigation of COVID 19 mutations and to bring a new vaccine for humans against the virus The corona for preclinical in vivo tests within 90 days. As part of the fight against COVID 19, Dassault Systèmes' 3DEXPERIENCE platform and digital applications can help the health ecosystem and meet the needs of research and clinical development, production and patient care.
By using BIOVIA for COVID 19 research and development, MiGl's research institute can guide its laboratory and experiment management processes with a digital approach that accelerates research results. Its scientists can quickly process and analyze the research data collected over the past four years and build models of viral protein behavior and the evolution of its predicted neutralization epitopes. This allows Miguel to analyze the test results from various aspects of past research and decide which research strategies to use in the future.
More of the topic in Hayadan:
- An Israeli vaccine for avian coronavirus will be adapted for humans and undergo a clinical trial
- The search for the next pandemic
- The Ministry of Science and Technology is investing in more than 80 urgent studies in the field of the Corona virus
